18 Nov Pfizer ready for vaccine authorization
Pfizer says it has accumulated enough safety data on its Covid-19 vaccine and is preparing to file for emergency use authorization from the US Food and Drug Administration.
Last week, the company released early clinical trial data showing its vaccine is more than 90% effective, and said it was waiting to apply to the FDA until it had gathered sufficient data on the safety of the vaccine.
The company’s CEO Albert Bourla said in an interview hosted by The New York Times, “I think the questions about the safety at large also have been answered.
“Our safety milestone has been achieved already, and we are preparing now for submissions.”
Moderna, another pharmaceutical company, announced Monday that early results from their clinical trials show their vaccine is 94.5% effective. The company plans to apply to the FDA for authorization soon after it accumulates more safety data later this month.
Sorry, the comment form is closed at this time.